A Novel Quaternary Ammonium N-Propylamiodarone Bromide Provides Long-Lasting Analgesia Against Corneal Pain
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s486031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Yumi Kotoda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan. Hauptthemen laut MEDLINE: Rats, Wistar, Quaternary Ammonium Compounds. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
- Department of Anesthesiology, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
- F.M. Kirby Neurobiology Center and Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
- Department of Neurobiology, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Masakazu Kotoda
Zitieren
APA
Kotoda, Y., Hishiyama, S., Shim, J., Kobayashi, H., Takamino, A., Abe, M., Kashiwagi, K., Matsukawa, T., & Kotoda, M. (2024). A Novel Quaternary Ammonium N-Propylamiodarone Bromide Provides Long-Lasting Analgesia Against Corneal Pain. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s486031
Vancouver
Kotoda Y, Hishiyama S, Shim J, Kobayashi H, Takamino A, Abe M, et al. A Novel Quaternary Ammonium N-Propylamiodarone Bromide Provides Long-Lasting Analgesia Against Corneal Pain. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s486031
BibTeX
@article{Kotoda2024,
author = {Kotoda, Yumi and Hishiyama, Sohei and Shim, Jaehoon and Kobayashi, Hiroki and Takamino, Ayasa and Abe, Masako and Kashiwagi, Kenji and Matsukawa, Takashi and Kotoda, Masakazu},
title = {A Novel Quaternary Ammonium N-Propylamiodarone Bromide Provides Long-Lasting Analgesia Against Corneal Pain},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s486031}
}
EUVIMED